Dr Lalchandani Labs Ltd - 541299 - Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Year Ended 31St March, 2022.
Certificate Issued In Compliance of Regulation 40(9) of The Provision of SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015 for the year ended 31st March, 2022. Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate For The Period Ended March 31, 2022
Compliance Certificate under Regulation 7(3) for the period ended March 31, 2022. Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Dr Lalchandani Labs Limited has informed the Exchange regarding the Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2022. Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SWATI PODDARDesignation :- Company Secretary and Compliance Officer Dr Lalchandani Labs Ltd - 541299 - Announcement- Grant Of The Empanelment Of Airports Authority Of India (AAI)
''''Dr Lalchandani Labs Limited'''' would like to announce that we have been granted the Empanelment of the Airports Authority of India (AAI) to provide Pathology and Radiology Services. Dr Lalchandani Labs Ltd - 541299 - Closure of Trading Window
We hereby inform you that in accordance with the Company''s Code of Conduct for Insider Trading read with applicable provisions of SEBI (Prohibition of Insider Trading ) Regulation, 2015 the Trading Window for dealing in the Company''s Share / Securities by all the Directors, Promoters, Officers, Designated Employees and other connected persons such as auditors, consultants, and their immediate relatives shall remain closed from Friday, 1st April, 2022 and will open 48 hours after the announcement of the Audited Financial Results for the financial year ended on March 31, 2022 to the Exchanges (both days inclusive). The date of the Board Meeting for approval and adoption of the Audited Financial Results for the financial year ended on March 31, 2022 will be intimated to the Exchanges in due course. Kindly take the above document on your record and acknowledge. Dr Lalchandani Labs Ltd - 541299 - Announcement- Grant Of The Empanelment Of Delhi Municipal Corporation (DMC).
''Dr Lalchandani Labs Limited'' would like to announce that we have been granted the Empanelment of Delhi Municipal Corporation (DMC) to provide diagnostic facilities. Dr Lalchandani Labs Ltd - 541299 - Announcement- Grant Of The Empanelment Of Delhi Government Employees Health Scheme (DGEHS).
'Dr Lalchandani Labs Limited' would like to announce that recently we have been granted the Empanelment of Delhi Government Employees Health Scheme (DGEHS). Dr Lalchandani Labs Ltd - 541299 - Intimation Regarding Appointment Of Internal Auditor.
Intimation is hereby given that DR LALCHANDANI LABS LIMITED has appointed M/s Vikas Bagga & Co. as an Internal Auditor. Dr Lalchandani Labs Ltd - 541299 - Appointment Of Additional Director
Dr Lalchandani Labs Limited would like to inform that Ms. Swati Chandra (DIN No.: 0009514968) has been appointed as a Additional Director (Non-Executive Director) of the Company with effect from 09th March, 2022.